<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02516540</url>
  </required_header>
  <id_info>
    <org_study_id>LIBRE-2-20150626</org_study_id>
    <nct_id>NCT02516540</nct_id>
  </id_info>
  <brief_title>Efficacy of Lifestyle Intervention in BRCA1/2 Mutation Carriers</brief_title>
  <acronym>LIBRE-2</acronym>
  <official_title>Prospective Randomized Multicenter Trial to Assess the Efficacy of a Structured Physical Exercise Training and Mediterranean Diet in Women With BRCA1/2 Mutations</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Technische Universität München</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Hohenheim</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital Schleswig-Holstein</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Leipzig</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Cologne</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Technische Universität München</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The hypothesis of this 3 year, prospective randomized multicenter efficacy trial is that a&#xD;
      structured life-style intervention program with exercise training and mediterranean diet is&#xD;
      effective regarding increased adherence to a mediterranean diet, reduction of body mass&#xD;
      index, and increase of physical fitness.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      BRCA1/2 mutation carriers have a considerably increased risk to develop breast and ovarian&#xD;
      cancer during their lifetime. There is evidence from the literature that for sporadic breast&#xD;
      cancer disease risk and the course of disease can be significantly influenced by physical&#xD;
      activity, nutrition and weight. The hypothesis of this 3 year, prospective randomized&#xD;
      multicenter efficacy trial is that a structured life-style intervention program with exercise&#xD;
      training and mediterranean diet is effective regarding increased adherence to a mediterranean&#xD;
      diet, reduction of body mass index, and increase of physical fitness.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 2015</start_date>
  <completion_date type="Anticipated">March 2025</completion_date>
  <primary_completion_date type="Anticipated">March 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mediterranean Diet Adherence Screener (MEDAS) Score (Questionnaire)</measure>
    <time_frame>12 months</time_frame>
    <description>Adherence to mediterranean diet</description>
  </primary_outcome>
  <primary_outcome>
    <measure>body mass index (BMI)</measure>
    <time_frame>12 months</time_frame>
    <description>Body weight (in kilograms) divided by body height (in meters) squared.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>ventilatory threshold 1 (VT1) in spiroergometry</measure>
    <time_frame>12 months</time_frame>
    <description>ventilatory threshold VT1 in spiroergometry</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>stress coping capacity, as measured by the Trier Inventory for Chronic Stress (TICS) questionnaire</measure>
    <time_frame>3, 12, 24, 36 months</time_frame>
    <description>(TICS) questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>grade of optimism, as measured by the Life Orientation Test (LOT) questionnaire</measure>
    <time_frame>3, 12, 24, 36 months</time_frame>
    <description>Life Orientation Test (LOT)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>attitudes and beliefs regarding physical training and healthy diet, as measured by the &quot;Bewertung körperlicher Aktivität und Ernährung&quot; (BKAE) questionnaire</measure>
    <time_frame>3, 12, 24, 36 months</time_frame>
    <description>(BKAE) questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>quality of life, as measured by the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30 (EORTC QLQ-C30)</measure>
    <time_frame>3, 12, 24, 36 months</time_frame>
    <description>(EORTC QLQ-C30)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>maximum oxygen consumption (VO2max), as measured by spiroergometry</measure>
    <time_frame>3, 12 months</time_frame>
    <description>spiroergometry</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>physical activity, as measured by the International Physical Activity Questionnaire (IPAQ)</measure>
    <time_frame>3, 12, 24, 36 months</time_frame>
    <description>Physical Activity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>incidence of breast cancer</measure>
    <time_frame>12, 24, 36 months</time_frame>
    <description>During study</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mediterranean Diet Adherence Screener (MEDAS) Score</measure>
    <time_frame>3, 6, 9, 12, 24, 36 months</time_frame>
    <description>(MEDAS) Score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>body mass index (BMI)</measure>
    <time_frame>3, 12, 24, 36 months</time_frame>
    <description>(BMI)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change of maximum oxygen consumption (VO2max) at ventilation threshold 1 (VT1), as measured by spiroergometry</measure>
    <time_frame>3, 12 months</time_frame>
    <description>spiroergometry</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>mortality rate</measure>
    <time_frame>12, 24, 36 months</time_frame>
    <description>During study</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>satisfaction (questionnaire)</measure>
    <time_frame>3, 12, 24, 36 months</time_frame>
    <description>satisfaction (questionnaire)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>tobacco consumption</measure>
    <time_frame>12, 24, 36 months</time_frame>
    <description>survey</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>alcohol consumption</measure>
    <time_frame>12, 24, 36 months</time_frame>
    <description>survey</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>dietary habits and calory intake, as measured by the European Prospective Investigation into Cancer and Nutrition Study Food Frequency Questionnaire (EPIC-FFQ)</measure>
    <time_frame>3, 12, 24, 36 months</time_frame>
    <description>(EPIC-FFQ)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>serum cholesterol, serum high density lipoprotein cholesterol,serum, serum Glucose, triglycerides, c-reactive Protein, serum Insulin,proneurotensin</measure>
    <time_frame>3, 12, 24, 36 months</time_frame>
    <description>Blood Test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>proenkephalin</measure>
    <time_frame>3, 12, 24, 36 months</time_frame>
    <description>Genetic test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Omega 3 fatty acid in the erythrocyte Membrane, Omega 6 fatty acid level in the erythrocyte Membraserum low density, lipoprotein cholesterolne, Omega 9 fatty acid level in the erythrocyte Membrane,</measure>
    <time_frame>3, 12, 24, 36 months</time_frame>
    <description>Blood Test</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">600</enrollment>
  <condition>Hereditary Breast and Ovarian Cancer</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Study participants are instructed regarding a healthy diet according to the recommendations of the German Nutrition Society (DGE) and are informed about positive effects of physical activity on incidence and prognosis of breast cancer</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Structured exercise training plus mediterranean diet: Study participants receive a lifestyle intervention of 12 months duration (3 months intensive intervention plus 9 months maintenance using monthly contacts and meetings). The intervention comprises a structured intensified training based on the results of physical performance diagnostics and a nutrition program based on a mediterranean diet.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Structured exercise training plus mediterranean diet</intervention_name>
    <description>Structured exercise training plus mediterranean diet</description>
    <arm_group_label>Intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  proven pathogenic BRCA1/2 mutation&#xD;
&#xD;
          -  age &gt;=18&#xD;
&#xD;
          -  written informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  current chemotherapy of radiotherapy (inclusion 6 weeks after CTX or RX possible)&#xD;
&#xD;
          -  metastatic tumor disease&#xD;
&#xD;
          -  life expectancy &lt;3 years&#xD;
&#xD;
          -  clinically limiting cardiovascular or respiratory disease (instable CVD, heart failure&#xD;
             stage IV, COPD GOLD IV, maximum resting blood pressure 160/100 mmHg)&#xD;
&#xD;
          -  significant orthopedic disability which prevents from participating in the group&#xD;
             interventions&#xD;
&#xD;
          -  severe concomitant diseases which prevents from participating in the group&#xD;
             interventions&#xD;
&#xD;
          -  Karnofsky index &lt;60&#xD;
&#xD;
          -  maximum exercise capacity &lt;50 W&#xD;
&#xD;
          -  food allergies which prevent from mediterranean diet&#xD;
&#xD;
          -  vegan diet&#xD;
&#xD;
          -  body mass index &lt;15 kg/m2&#xD;
&#xD;
          -  pregnancy&#xD;
&#xD;
          -  insufficient knowledge of German language&#xD;
&#xD;
          -  insufficient compliance&#xD;
&#xD;
          -  active participation in other interventional trials&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marion Kiechle, Prof. Dr.</last_name>
    <role>Study Director</role>
    <affiliation>Technische Universität München</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Martin Halle, Prof. Dr.</last_name>
    <role>Study Director</role>
    <affiliation>Technische Universität München</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Stephan C Bischoff, Prof. Dr.</last_name>
    <role>Study Director</role>
    <affiliation>Universitaet Hohenheim, Stuttgart</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Michael Siniatchkin, Prof. Dr.</last_name>
    <role>Study Director</role>
    <affiliation>Universitätsklinikum Schleswig-Holstein, Campus Kiel</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Markus Loeffler, Prof. Dr.</last_name>
    <role>Study Director</role>
    <affiliation>University of Leipzig</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Christoph Engel, PD Dr.</last_name>
    <role>Study Director</role>
    <affiliation>University of Leipzig</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Rita K Schmutzler, Prof. Dr.</last_name>
    <role>Study Director</role>
    <affiliation>University of Cologne</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Alfons Meindl, Prof. Dr.</last_name>
    <role>Study Director</role>
    <affiliation>Technische Universität München</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Anne S Quante, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Technische Universität München</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Marion Kiechle, Prof. Dr.</last_name>
    <phone>+49 89 4140 2420</phone>
    <email>marion.kiechle@tum.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Daniela Schemmer</last_name>
    <phone>+49 89 4140 2433</phone>
    <email>Daniela.Schemmer@mri.tum.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Humboldt Universität zu Berlin</name>
      <address>
        <city>Berlin</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden</name>
      <address>
        <city>Dresden</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Düsseldorf</name>
      <address>
        <city>Düsseldorf</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Kliniken Essen-Mitte</name>
      <address>
        <city>Essen</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Essen</name>
      <address>
        <city>Essen</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Freiburg</name>
      <address>
        <city>Freiburg</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Universitätsmedizin Göttingen</name>
      <address>
        <city>Göttingen</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Hamburg-Eppendorf</name>
      <address>
        <city>Hamburg</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Medizinische Hochschule Hannover</name>
      <address>
        <city>Hannover</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Universitätsklinium Heidelberg</name>
      <address>
        <city>Heidelberg</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Schleswig-Holstein, Campus Kiel</name>
      <address>
        <city>Kiel</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Uniklinikum Köln</name>
      <address>
        <city>Köln</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Leipzig</name>
      <address>
        <city>Leipzig</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Technische Universität München</name>
      <address>
        <city>München</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Universität Regensburg</name>
      <address>
        <city>Regensburg</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Interdisziplinäres Brustzentrum am Diakonieklinikum</name>
      <address>
        <city>Stuttgart</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Tübingen</name>
      <address>
        <city>Tübingen</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Universität Ulm</name>
      <address>
        <city>Ulm</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Würzburg</name>
      <address>
        <city>Würzburg</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>July 22, 2015</study_first_submitted>
  <study_first_submitted_qc>August 3, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 6, 2015</study_first_posted>
  <last_update_submitted>April 10, 2021</last_update_submitted>
  <last_update_submitted_qc>April 10, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 14, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>hereditary breast and ovarian cancer (HBOC)</keyword>
  <keyword>BRCA1/2 mutation carriers</keyword>
  <keyword>Mediterranean diet</keyword>
  <keyword>Structured exercise training</keyword>
  <keyword>prevention</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ovarian Neoplasms</mesh_term>
    <mesh_term>Hereditary Breast and Ovarian Cancer Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

